Vol. 55 No. 3 (2016): Acta Oncologica

Articles

• Does long-term survival exist in pancreatic adenocarcinoma?

  Myrte Zijlstra, Nienke Bernards, Ignace H. J. T. de Hingh, Agnes J. van de Wouw, Swan Hoo Goey, Esther M. G. Jacobs, Valery E. P. P. Lemmens, Geert-Jan Creemers

  259-264

  Published: 2016-03-03

  • PDF

• Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study

  Hugo J. A. dams, John M. H. de Klerk, Rob Fijnheer, Ben G. F. Heggelman, Stefan V. Dubois, Rutger A. J. Nievelstein, Thomas C. Kwee

  386-390

  Published: 2016-03-03

  • PDF

• Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer

  Talha Shaikh, Mark A. Zaki, Michael M. Dominello, Elizabeth Handorf, Andre A. Konski, Steven J. Cohen, Anthony Shields, Philip Philip, Joshua E. Meyer

  303-308

  Published: 2016-03-03

  • PDF

• Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell

  Elisabeth Beisland, Hans J. Aarstad, Anne K. H. Aarstad, August Bakke, Leif Bostad, Christian Beisland

  349-356

  Published: 2016-03-03

  • PDF

• Syndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide

  Yoshinori Yanai, Kazuhiro Matsumoto, Naoya Niwa, Takeo Kosaka, Eiji Kikuchi, Akira Miyajima, Hiroshi Ito, Mototsugu Oya

  399-400

  Published: 2016-03-03

  • PDF

• Interobserver variation among pathologists for delineation of tumor on H&E-sections of laryngeal and hypopharyngeal carcinoma. How good is the gold standard?

  Elise Anne Jager, Stefan M. Willems, Tim Schakel, Nina Kooij, Pieter J. Slootweg, Marielle E. P. Philippens, Joana Caldas-Magalhaes, Chris H. J. Terhaard, Cornelis P. J. Raaijmakers

  391-395

  Published: 2016-03-03

  • PDF

• Staging and therapy for patients with hepatocellular cancer in a defined population from 2000 to 2011 – active palliative treatment improved overall survival

  Per Lindnér, Erik Holmberg, Magnus Rizell, Larsolof Hafström

  Published: 2023-11-07

  • PDF

• Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)

  Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, Hiroyuki Kaneto, Hiroyuki Okuda, Masanori Nojima, Takeshi Hagiwara, Kazuya Suzuki, Takeya Adachi, Akira Goto, Kohei Nakachi, Atsushi Yawata, Mitsuru Yoshimoto, Tokuma Tanuma, Yasushi Adachi, Satoshi Yamaoka, Tsunenori Mizukoshi, Mariko Kawayama, Yasuo Hamamoto, Yasuhisa Shinomura

  309-317

  Published: 2016-03-03

  • PDF

• Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor

  Anne Sacré, Philippe Barthélémy, Clement Korenbaum, Mickael Burgy, Pascal Wolter, Herlinde Dumez, Evelyne Lerut, Tine Loyson, Steven Joniau, Raymond Oyen, Philip R. Debruyne, Patrick Schöffski, Benoit Beuselinck

  329-340

  Published: 2016-03-03

  • PDF

• Second primary malignancy in Burkitt's lymphoma

  Binay Kumar Shah, Nibash Budhathoki

  396-398

  Published: 2016-03-03

  • PDF

• Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer

  Jacob Elebro, Liv Ben Dror, Margareta Heby, Björn Nodin, Karin Jirström, Jakob Eberhard

  286-296

  Published: 2016-03-03

  • PDF

• Incidence of cancer among grand multiparous women in Finland with special focus on non-gynaecological cancers: A population-based cohort study

  Emma Högnäs, Antti Kauppila, Marianne Hinkula, Juha S. Tapanainen, Eero Pukkala

  370-376

  Published: 2016-03-03

  • PDF

• The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

  Bettina Butzke, Fuat S. Oduncu, Franziska Severin, Arne Pfeufer, Volker Heinemann, Clemens Giessen-Jung, Björn Stollenwerk, Wolf H. Rogowski

  318-328

  Published: 2016-03-03

  • PDF

• Any progress in pancreatic cancer?

  Bengt Glimelius

  255-258

  Published: 2016-03-03

  • PDF

• Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands

  Lydia G. M. van der Geest, Marc G. H. Besselink, Yvette R. B. M. van Gestel, Olivier R. C. Busch, Ignace H. J. T. de Hingh, Koert P. de Jong, I. Quintus Molenaar, Valery E. P. P. Lemmens

  278-285

  Published: 2016-03-03

  • PDF

• BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping

  Maja Bendtsen Sharma, Andreas Carus, Lone Sunde, Stephen Hamilton-Dutoit, Morten Ladekarl

  377-381

  Published: 2016-03-03

  • PDF

• Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma

  Päivi Siironen, Jaana Hagström, Hanna O. Mäenpää, Johanna Louhimo, Johanna Arola, Caj Haglund

  357-364

  Published: 2016-03-03

  • PDF

• Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma – A population-based cohort study

  Knut J. Labori, Matthew H. Katz, Ching W. Tzeng, Bjørn A. Bjørnbeth, Milada Cvancarova, Bjørn Edwin, Elin H. Kure, Tor J. Eide, Svein Dueland, Trond Buanes, Ivar P. Gladhaug

  265-277

  Published: 2016-03-03

  • PDF

• Gemcitabine, capecitabine and oxaliplatin with or without cetuximab in advanced biliary tract carcinoma

  Finn Ole Larsen, Dan Taksony Solyom Hoegdall, Estrid Hoegdall, Dorte Nielsen

  382-385

  Published: 2016-03-03

  • PDF

• Determinants of long-term quality of life in patients with differentiated thyroid carcinoma – a population-based cohort study in Sweden

  Christel Hedman, Therese Djärv, Peter Strang, Catharina Ihre Lundgren

  365-369

  Published: 2016-03-03

  • PDF

• A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2

  Anne V. Soerensen, Poul F. Geertsen, Ib J. Christensen, Gregers G. Hermann, Niels V. Jensen, Kirsten Fode, Astrid Petersen, Rickard Sandin, Frede Donskov

  341-348

  Published: 2016-03-03

  • PDF